DHEA Sulfate Test · Blood

Your adrenal glands sit on top of your kidneys and quietly produce the single most abundant hormone circulating in your blood: DHEA-S (dehydroepiandrosterone sulfate). Your body uses it as raw material to build testosterone, estrogen, and other hormones in tissues throughout the body. The level you carry right now reflects how much of that raw material your adrenals are still producing, and it drops sharply as you age.

That decline matters. In men with existing heart disease, those with the lowest DHEA-S levels had about 28% higher risk of dying from any cause compared to those with the highest levels, according to a meta-analysis of cardiovascular patients. In women, low DHEA-S has been linked to worse lung function, impaired immune activity, and lower bone density. Yet DHEA-S is almost never included on a standard wellness panel, which means you can look perfectly healthy on paper while this number quietly slides into a range associated with real risk.

What DHEA-S Tells You

DHEA-S is the sulfated, storage form of DHEA. Your adrenal glands attach a sulfate group to DHEA, which makes it more water-soluble and gives it a long half-life in the blood (roughly 10 to 20 hours). Because of this stability, DHEA-S does not bounce around the way cortisol does throughout the day. A single blood draw gives you a reliable snapshot of your chronic adrenal androgen output.

Once DHEA-S reaches your tissues (bone, brain, skin, fat, muscle), local enzymes strip off the sulfate group and convert it into active hormones: testosterone, estrogen, and their downstream products. This local conversion, sometimes called intracrine synthesis, is especially important for women after menopause, when the ovaries produce less estrogen and the adrenal pathway becomes a primary hormonal source.

The Age Curve

DHEA-S follows one of the most dramatic age-related declines of any hormone in the human body. Levels peak somewhere in your mid-twenties, then fall by roughly 70 to 80% by the time you reach your fifties or sixties. A large observational study of healthy adults confirmed this steep, continuous drop in both men and women, with women producing approximately 66% of the total androgens found in men at any given age.

This decline is not just a number on a lab report. Eight common genetic variants associated with DHEA-S levels have been linked to aging mechanisms, suggesting that the rate at which your DHEA-S falls may reflect something fundamental about how your body ages. The ratio of cortisol (your main stress hormone) to DHEA-S appears to track biological aging even more closely than either hormone alone: a higher cortisol-to-DHEA-S ratio has been identified as the best predictor of accelerated epigenetic aging in a study of nearly 1,000 adults.

Heart Disease and Mortality Risk

The link between low DHEA-S and cardiovascular death is one of the most studied associations for this hormone. In the landmark Rancho Bernardo study, men aged 50 to 79 with DHEA-S below 140 micrograms per deciliter had roughly three times the risk of cardiovascular death compared to those with higher levels over 12 years of follow-up. That association held after adjusting for blood pressure, cholesterol, obesity, blood sugar, and smoking.

A systematic review and meta-analysis of patients with existing cardiovascular disease confirmed the pattern: lower DHEA-S was associated with significantly higher risk of dying from any cause, fatal cardiovascular events, and nonfatal cardiovascular events. In the large ARIC study (Atherosclerosis Risk in Communities), which followed over 8,900 adults for a median of 19.2 years, each standard-deviation decrease in DHEA-S was linked to about 17% higher risk of developing heart failure in postmenopausal women and about 7% higher risk in men.

A dose-response meta-analysis pooling six general-population studies found that men in the highest DHEA-S category had about 28% lower all-cause mortality compared to those in the lowest category. In women, however, this same meta-analysis found no clear independent association between DHEA-S and overall mortality after adjusting for confounders. This sex difference is consistent across much of the literature.

Bone Health

A Mendelian randomization study, which uses genetic variants to estimate causal effects, found that higher genetically predicted DHEA-S levels were causally linked to increased lumbar spine bone mineral density and decreased forearm fracture risk in women. This kind of evidence is stronger than a simple correlation because it reduces the chance that some other factor is driving both low DHEA-S and weak bones.

Supplementation trials support this finding to a degree. In the DAWN trial, 225 healthy older adults who took 50 milligrams of DHEA daily for one year showed modest gains in lumbar spine bone density and reduced bone-breakdown markers, but only in women. Men saw no bone benefit despite similar increases in DHEA-S levels.

Brain Function and Mood

In a study of 295 women, higher endogenous DHEA-S levels were independently associated with better executive function, concentration, and working memory after accounting for age, education, mood, and other hormones. Brain tissue analysis from people with Alzheimer's disease has also shown lower neurosteroid levels (including DHEA-S) compared to people without the disease, with higher levels of amyloid plaques correlating with lower neurosteroid concentrations.

In a randomized trial of 39 people with Addison's disease (a condition where the adrenal glands fail and DHEA-S drops to near zero), DHEA replacement improved mood and reduced fatigue. A separate, small open trial in six middle-aged and elderly patients with depression also suggested antidepressant and memory-enhancing effects. These are encouraging signals, but the evidence is limited in both size and scope.

Immune Function

Your immune system appears to respond to DHEA-S levels. In a cross-sectional study of 2,275 adults, higher DHEA-S was associated with better natural killer cell activity (your body's first-line defense against infected or cancerous cells) in premenopausal women. Low DHEA-S has also been found in women with autoimmune conditions like Sjogren's syndrome, where it correlated with disease severity and inflammation.

Breast Cancer: A Counterbalancing Risk

Not every association with DHEA-S points in the same direction. In postmenopausal women, higher serum DHEA and DHEA-S levels have been associated with increased breast cancer risk. A nested case-control study within a cohort of over 7,000 women found that those in the highest DHEA-S quintile (top 20%) had about 74% higher odds of breast cancer compared to the lowest quintile.

This is not as contradictory as it sounds. DHEA-S is a raw material for estrogen production. When researchers in the same study adjusted for estrone (the primary postmenopausal estrogen), the DHEA-S association largely disappeared, suggesting that the breast cancer risk comes from the estrogen that DHEA-S gets converted into, not from DHEA-S itself. This means the same process that supports bone density and brain function in women can also feed estrogen-sensitive cancers. The takeaway is that DHEA-S is not a simple "more is better" number, especially for postmenopausal women.

The U-Shaped Curve in Older Women

A study of 539 disabled older women in the Women's Health and Aging Study found that mortality risk followed a U-shaped pattern: women in both the lowest and highest DHEA-S quartiles had more than double the five-year mortality risk compared to women in the middle quartiles, after adjusting for confounders. This argues against chasing the highest possible DHEA-S level and suggests that a mid-range value, appropriate for your age and sex, is the healthiest target.

Reference Ranges

DHEA-S reference ranges are strongly age- and sex-dependent, and no single universal "optimal" cutpoint exists. Labs use different assays (immunoassay or the more precise technique called liquid chromatography-tandem mass spectrometry, or LC-MS/MS), and cutoffs can vary between them. The ranges below are drawn from published clinical research and are meant as orientation, not rigid targets. Always compare your results within the same lab over time.

Some endocrine workups use an age- and sex-adjusted DHEA-S ratio (your measured level divided by the lower limit of the reference range for your age and sex group) rather than a raw number. In one adrenal incidentaloma study, a ratio of 1.12 or below had greater than 99% sensitivity and about 92% specificity for detecting subclinical cortisol overproduction. Ask your lab whether they provide age-specific reference intervals.

When Results Can Be Misleading

DHEA-S is analytically stable, with intra-assay variation of roughly 1 to 4% and inter-assay variation around 3%. It has minimal circadian rhythm, so morning vs afternoon draws cause less distortion than they do for cortisol. Still, several factors can shift your number in ways that do not reflect your true adrenal health.

• Glucocorticoid medications (prednisone, dexamethasone): Systemic steroids suppress ACTH (adrenocorticotropic hormone, the pituitary signal that drives your adrenals), which lowers DHEA-S. This suppression can persist for weeks to months after stopping the medication. A low DHEA-S in someone on or recently off steroids reflects drug-induced adrenal quieting, not primary adrenal failure.
• Acute illness or recent surgery: Critical illness, particularly sepsis, can drop DHEA-S acutely as the adrenal glands shift resources toward cortisol production. If you are recovering from a serious illness or hospitalization, wait until you are in stable health before testing.
• Chronic opioid use: Sustained-action opioids can suppress DHEA-S in a dose-related fashion, with 67% of chronic opioid users having levels below age norms. This appears to be direct adrenal inhibition rather than a central brain-signal problem.
• Age and sex mismatch in interpretation: A DHEA-S of 80 µg/dL means something very different in a 25-year-old man than in a 65-year-old woman. Any result must be interpreted against age- and sex-specific reference ranges from the same lab.

Tracking Your Trend

Because DHEA-S declines predictably with age, a single reading tells you where you stand at one moment, but a trend over time tells you whether your decline is typical or accelerating. Two readings a year or more apart, drawn at the same lab, give you a personal trajectory. If you are making changes (starting DHEA supplementation, reducing opioid use, managing stress), retesting in three to six months shows whether those changes are actually moving the number.

For someone with no known adrenal issues who is simply tracking aging biology, an annual test is reasonable. If you have a diagnosed condition like adrenal insufficiency or PCOS, your endocrinologist may check more frequently, especially when adjusting treatment.

What to Do With an Abnormal Result

A DHEA-S result that falls well below your age- and sex-matched range should prompt a few next steps. First, retest once in stable health to confirm the finding, especially if you were recently ill, stressed, or on corticosteroids. Second, check a morning cortisol and ACTH (adrenocorticotropic hormone) to assess whether the adrenal glands and pituitary are working together properly. If those are also low, your doctor may recommend a stimulation test (a procedure where a synthetic version of ACTH is injected to see if your adrenals respond).

A very high DHEA-S for your age and sex, especially in a woman with acne, excess hair growth, or irregular periods, should be evaluated alongside total and free testosterone, androstenedione, and SHBG (sex hormone binding globulin, the protein that carries sex hormones in the blood) to distinguish between PCOS and rarer conditions like adrenal tumors or congenital adrenal hyperplasia. If DHEA-S is markedly elevated and discordant with age norms, imaging of the adrenal glands may be warranted.

For someone whose DHEA-S is low-normal and trending downward over serial readings, the decision is more nuanced. The cardiovascular and bone data favor keeping levels in at least a mid-range for your age group, but the breast cancer and U-shaped mortality data caution against pushing levels high. An endocrinologist can help weigh these factors against your personal risk profile.